Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond

Item

http://www.wikidata.org/entity/Q36619933

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond

@ast

Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond

@en

type

Item

label

Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond

@ast

Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond

@en

prefLabel

Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond

@ast

Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond

@en

P1476

Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond

@en

P2093

A D Forman

http://www.w3.org/2001/XMLSchema#string

E I Obeid

http://www.w3.org/2001/XMLSchema#string

G Mantia-Smaldone

http://www.w3.org/2001/XMLSchema#string

M B Daly

http://www.w3.org/2001/XMLSchema#string

M J Hall

http://www.w3.org/2001/XMLSchema#string

S C Schwartz

http://www.w3.org/2001/XMLSchema#string

P2860

The BRCT domain is a phospho-protein binding domain

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America

Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas

Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

Effect of Screening on Ovarian Cancer Mortality

PMS2 monoallelic mutation carriers: the known unknown

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions

P304

565-574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YGYNO.2016.01.019

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

140

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26812021

http://www.w3.org/2001/XMLSchema#string

P932

4767686

http://www.w3.org/2001/XMLSchema#string